There are a range of treatment options for men diagnosed with prostate cancer ranging from active surveillance to a range of active treatments and combinations of treatment modalities.
Each year some 240,000 men are diagnosed in the U.S.
Researchers are working to tailor treatments to each patient. Jefferson radiation oncologist Adam Dicker, MD, PhD, chair of the Department of Radiation Oncology, recently spoke with the Wall Street Journal about how prostate cancer treatment is changing.
For example, some men have better outcomes when treating their cancer with surgery and radiation rather than just one modality.
“Research from clinical trials suggests that giving radiation soon after surgery increases the time a patient lives without the disease coming back,” says Dr. Dicker in the article.
Genetic tests have also recently become available to predict whether a patient is at high or low risk. These tests offer a more personalized approach to prostate cancer. They can help doctors recommend treatments, prevent over-diagnosis and ultimately increase survival rates.
Read the full article here.